Novo Nordisk, the parent company of Wegovy, told Newsweek that this study "highlights the chronic nature of obesity and suggest that ongoing treatment is necessary." Eli Lilly and Company, the parent company of Mounjaro, told Newsweek : "When treatment is stopped, weight can return, which reflects the biology of the condition rather than a lack of effort." Newsweek reached out to the Centers for Disease Control and Prevention (CDC) via email for comment
We did not try to quantify these successive negative inotropic effects of receptor antagonists as one antagonist may have altered the effect of another
Retatrutides 24.2% average weight loss in Phase 2 trials represents the highest ever recorded in obesity pharmacotherapy
Why Sublingual Glutathione is Superior Higher absorption rate than oral capsules or powders
Understanding how semaglutide works and how it interacts with common illnesses like the flu is important for patients, healthcare providers, and anyone interested in modern medicine
The rescue experiment suggests that GSTM2 may be a useful therapeutic target for hepatic steatosis